Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Denosumab for Acute Charcot Neuro-osteoarthropathy in CKD
NCT05797259Phase 4Completed
- Sponsor
- Post Graduate Institute of Medical Education and Research
- Start
- Mar 2019
- Primary completion
- Mar 2023
- Countries
- 1
01
Overview
A Phase 4 trial of denosumab in Charcot neuro-osteoarthropathy (CN), sponsored by Post Graduate Institute of Medical Education and Research. Started Mar 2019; status: completed.
02
Drugs
denosumab
03
Conditions
Charcot neuro-osteoarthropathy (CN)
Beyond the preview
Go deeper on NCT05797259.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05797259.